SELECTBIO Conferences Immuno-Oncology Europe 2019
Immuno-Oncology Europe 2019
-癌症免疫治疗学会欧洲大会:2019-
日期:2019年10月28-29日
地点:荷兰,鹿特丹,Rotterdam Marriott

专题演讲者

Stephen Beers

Stephen Beers
Professor of Immunology and Immunotherapy, University of Southampton

Sara Colombetti

Sara Colombetti
Global Head Oncology Discovery Pharmacology, pharma Research and Early Development (pRED), Roche Innovation Center Zurich

Graham Pockley

Graham Pockley
Director and Professor, John van Geest Cancer Research Centre, Nottingham Trent University, CEO, multimmune GmbH

Elena Menietti

Elena Menietti
Scientist, Oncology Discovery Pharmacology, pharma Research and Early Development (pRED), Roche Innovation Center Zurich

Ed Schuuring

Ed Schuuring
Professor in Molecular Oncological Pathology, University Medical Center Groningen

概要

癌症免疫疗法是针对体内肿瘤靶区以活络免疫系统为目的的一系列技术,这些方法经科学证明已产生对应于癌症的治疗策略高临床效用,并获得临床支持。

SelectBIO主办的Immuno-Oncology Europe 2019免疫和肿瘤免疫疗法领域的重要意见领袖将齐聚一堂,讨论免疫疗法最新策略和合理并用传统抗癌治疗与免疫疗法的方法等。此外,也预定举行基于对癌症的免疫疗法和生物活体组织切片/液体活检的融合进展状况,互相影响并进化的领域研究者双方交换意见的单元。

在本次学会更会针对适合免疫疗法的「目标患者群」可以使用的生物标记和搭配诊断试剂(CDx)进行讨论。

请千万别错过这个可以零听研究人员和临床科学家的研究发表,并参加最新主题和临床资料讨论的珍贵机会。

募集海报发表

出席会议的同时,可以用海报发表研究成果。欲参加者,请在规定期限内缴交摘要,接受审查。

海报摘要提交截止日期: 2019年10月21日

议程主题

  • 对应免疫疗法的生物标记和搭配诊断试剂
  • 检查点抑制免疫疗法和非检查点抑制免疫治疗
  • 癌症免疫疗法的嵌合抗原受体(CAR)T细胞
  • 联合癌症免疫疗法
  • 免疫学活性和介入治疗的共刺激分子
  • 免疫调节抗体
  • 对应癌症免疫疗法的前临床动物模型
  • 在癌症免疫疗法的小分子药物
  • 讯号途径标靶化的治疗干预
  • 肿瘤微环境标靶化

募集展商与赞助商

关于赞助与展出详情欢迎随时来信或来电询问Global information Inc.

目前已确定的演讲者

Philip Arlen, President and CEO, Precision Biologics, Inc
Johan Baeck, VP, Clinical Development & Medical Affairs, Jounce Therapeutics
CJ Barnum, Director of Neuroscience, INmune Bio, Inc.
Mark Cragg, Professor and Chair in Experimental Cancer Biology, Centre for Cancer Immunology, University of Southampton, Southampton General Hospital
Saviz Ehyai, Product Specialist, CELLINK
Walter Ferlin, CSO, Light Chain Bioscience
David Giljohann, CEO, Exicure
Radhakrishnan Iyer, Co-Founder & Chief Scientific Officer, Spring Bank Pharmaceuticals, Inc.
James Legg, Senior Vice President of Research, Crescendo Biologics
Lorena Lerner, Vice President, Molecular Biology & Virology, Oncorus
Jeanette H W Leusen, Associate Professor & Head of Immunotherapy Group, University Medical Center Utrecht
Miles Rackliff, Senior Sales Manager - Northern Europe, IsoPlexis
Anish Suri, Senior vice President and Chief Scientific Officer, Cue Biopharma, Inc.
RJ Tesi, CEO/CMO, Inmune Bio Inc
Nathaniel Wang, Head of R&D, Synthetic Genomics


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Chinese
Japanese
Korean
English



免费电子邮件通知服务